Papers
2
Total Citations
22
H-Index
2
About
David Donath is a radiation oncologist whose research has advanced the precision and safety of stereotactic body radiotherapy (SBRT) and brachytherapy. His key contributions focus on improving treatment outcomes for challenging cancers, particularly locally advanced pancreatic cancer and prostate cancer. In a landmark single-center study, Donath demonstrated the feasibility and efficacy of SBRT for patients with locally advanced pancreatic cancer, achieving promising local control rates in a disease traditionally resistant to radiation. This work, cited 11 times, has helped expand the role of non-invasive, high-dose radiation in managing this aggressive malignancy. Additionally, Donath pioneered techniques to minimize complications in prostate brachytherapy. His analysis of 279 patients showed that combining virtual needle guidance with robotic seed delivery significantly reduced seed loss and pulmonary seed migration—a critical safety concern. This research, also with 11 citations, has directly influenced clinical protocols, enhancing the accuracy and safety of permanent seed implantation. Through these contributions, Donath has improved both the therapeutic index and patient experience in radiation oncology, establishing himself as a clinician-researcher dedicated to technical innovation and evidence-based practice.
Research Focus
Key Achievements
Top Papers
- 1
- 2